4th Quarter - Report

BLANK ROME GOVERNMENT RELATIONS for WALGREEN CO

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Quality, Security, and Accountability Act Issues related to related to pharmacists recognized as health care providers federally. No specific legislation.

LobbyistCovered position, as disclosed
KATHLEEN BLANCHARD —
ASHLEY DAVIS —
MALLOY MCDANIEL —
KRISTI REMINGTON —
SHIMON STEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 557 (113th), H.R. 1024 (113th), S. 957 (113th), S. 959 (113th)

Medicare/Medicaid MMM

Issues relating to the Sustainable Growth Rate (SGR). No specific legislation.

LobbyistCovered position, as disclosed
KATHLEEN BLANCHARD —
ASHLEY DAVIS —
MALLOY MCDANIEL —
SHIMON STEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.

LobbyistCovered position, as disclosed
KATHLEEN BLANCHARD —
ASHLEY DAVIS —
MALLOY MCDANIEL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 867 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.